Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,180,729
-
Share change
-
+188,982
-
Total reported value
-
$16,541,000
-
Put/Call ratio
-
15%
-
Price per share
-
$5.20
-
Number of holders
-
44
-
Value change
-
+$1,204,840
-
Number of buys
-
31
-
Number of sells
-
8
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q2 2017
As of 30 Jun 2017,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,180,729 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., EAM Investors, LLC, BARD ASSOCIATES INC, Leisure Capital Management, GEODE CAPITAL MANAGEMENT, LLC, Sio Capital Management, LLC, GROUP ONE TRADING, L.P., and Sterling Global Strategies LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.